Bacterial sepsis in newborns, also known as neonatal sepsis, is a serious medical condition characterized by a systemic infection in the first month of life. It is a leading cause of morbidity and mortality in newborns, particularly those born prematurely or with low birth weight. Bacterial sepsis can be classified into early-onset sepsis (EOS), which occurs within the first 72 hours of life, and late-onset sepsis (LOS), which occurs after 72 hours.

Causes and Risk Factors

The most common pathogens associated with neonatal sepsis include group B Streptococcus (GBS), Escherichia coli, Listeria monocytogenes, and various species of Staphylococcus. These pathogens can be transmitted from the mother to the baby during childbirth or through postnatal exposure. Premature birth, prolonged rupture of membranes, maternal colonization with pathogenic bacteria, and invasive procedures such as intubation and catheterization are significant risk factors for neonatal sepsis.

Clinical Presentation

Neonatal sepsis can present with nonspecific symptoms such as fever, hypothermia, poor feeding, lethargy, respiratory distress, and irritability. In severe cases, it can progress rapidly to septic shock, characterized by hypotension, poor perfusion, and multiorgan dysfunction.


Diagnosing neonatal sepsis can be challenging due to the nonspecific nature of its symptoms. Blood cultures remain the gold standard for confirming the presence of bacterial infection. Other diagnostic tests may include complete blood count (CBC), C-reactive protein (CRP) levels, and imaging studies such as chest X-rays and ultrasounds to assess for complications like pneumonia or abscesses.


Prompt initiation of antibiotic therapy is crucial in the management of neonatal sepsis. Empiric broad-spectrum antibiotics are often initiated while awaiting culture results. Supportive care including respiratory support, fluid resuscitation, and inotropic agents may be necessary for infants with severe sepsis or septic shock.


Preventive measures play a vital role in reducing the incidence of neonatal sepsis. This includes prenatal screening and treatment for maternal colonization with pathogenic bacteria, administration of intrapartum antibiotics to high-risk mothers, strict adherence to infection control practices in neonatal intensive care units (NICUs), and promoting breastfeeding to enhance the infant’s immune system.

In conclusion, bacterial sepsis in newborns is a critical condition that requires early recognition, prompt treatment, and preventive strategies to improve outcomes for affected infants.

One liner gk in ಕನ್ನಡ – top 2000  (36). Plastic mulching paper quantity.